Contribution of a metal-peroxide adduct to neurodegeneration is due to its oxidative protease activity

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 54, Issue 12, 1999, Pages 1107-1114

  Nishida, Yuzo ^a   Nishino, Satoshi ^a  

^a INSTITUTE FOR MOLECULAR SCIENCE   (Japan)

Author keywords

Cleavage of protein; Metal peroxide adduct; Neurodegenerative diseases; Oxidative protease function

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; COPPER PEROXIDE ADDUCT; ENZYME ACTIVITY; HYDROGEN PEROXIDE; METAL PEROXIDE ADDUCT; NERVE DEGENERATION; OXIDATIVE STRESS; PRION DISEASE; PROTEIN DEGRADATION; PROTEINASE; REACTION MECHANISM;

EID: 0033374350     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-1999-1217     Document Type: Article

References (41)

1. Behl C. (1999), Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog. Neurobiol. 57, 301-323.
2. Brown D. R., Herms J. W., Madlung A., Manson J., Strome R., Fraser P. E., Kruck T., Bohlens A., S.-Schaeffer W., Glese A., Westaway D. and Kretzschmar H. (1997), The cellular prion protein binds copper in vivo. Nature 390, 684-687.
3. Brown D. R., Schmidt B. and Kretzschmar H. A. (1998), Effects of copper on survival of prion protein knock-out neurons and glia. J. Neurochem. 70, 1686-1693.
4. Brown R. H. jr. (1995). Amyotrophic lateral sclerosis:recent insights from genetics and transgenic mice. Cell 80, 687-692.
5. Chin J. (1991), Developing artificial hydrolytic metallo-enzymes by a unified mechanistic approach, Acc. Chem. Res. 24, 145-152.
6. Deng et al. (1993), Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261, 1047-1051.
7. Double K. L., Maywald M., Schmittel M., Riedere P. and Gerlach M. (1998), In vitro studies of ferritin iron release and neurotoxicity. J. Neurochemistry 70, 2492-2499.
8. Fullerton H. J., Ditelberg J. S., Chen S. F., Sarco D. P., Chan P. H., Epstein C. J. and Ferriero D. M. (1998), Copper/Zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after prenatal hypoxia ischemia. Ann. Neurol. 44, 357-364.
9. Glockshuber R., Hornnemann S., Riek R., Wide G., Billeter M. and Wuthrich K. (1997), Three-dimensional NMR structure of a self-folding domain of the prion protein PrP(121-231). Trends Biochem. Sci. 22, 241-242.
10. Gerlach M., B.-Shachar D., Riedere P. and Youdim M. B. H. (1994), Altered brain metabolism of iron as a cause of neurodegenerative disease? J. Neurochem. 63, 793-807.
11. Hardy J. (1997), Amyloid, the presenilins and Alzheimer's disease. Trends Biochem. Sci. 20, 154-159.
12. Ishikawa Y., Ito S., Nishino S., Ohba S. and Nishida Y. (1998), Contribution of a peroxide adduct of copper(II)-peptide complex to modify the secondary structure of albumin. Z. Naturforsch. 53c, 378-382.
13. Ito S., Okuno T., Itoh H., Matsushima H., Tokii T. and Nishida Y. (1997), Chemical basis for high activity in oxygenation of cyclohexane catalyzed by dinuclear iron(III) complexes with ethereal oxygen containing ligands and hydrogen peroxide. Z. Naturforsch. 52b, 719-727.
14. Ito S., Ishikawa Y., Nishino S., Kobayashi T., Ohba S. and Nishida Y. (1998), Interaction between peroxide ion and phenol group which are coordinated to the same iron(III) ion. Polyhedron 17, 4379-4391.
15. 2 catalzyed by dinuclear iron(III) complexes with amide-containing ligands. J. Chem. Soc., Dalton Trans. 4479-4484.
16. Klinman J. P. (1996), Mechanism whereby mononuclear copper protein functionalize organic substrate. Chem. Rev. 96, 2541-2561.
17. Kobayashi T., Okuno, T., Suzuki T., Kunita M., Ohba S. and Nishida Y. (1998), DNA degradation by the copper(II) complex with tripodal-ligands containing peptide group. Polyhedron 17, 1553-1559.
18. Kosik K. S. (1999), A notable cleavage: Winding up with β-amyloid. Proc. Natl. Acad. Sci. USA 96, 2574-2576.
19. Loeffer D. A., Connor J. R., Juneau P. L., Snyder B. S., Kanaley L., DeMaggio A. J., Nguyen H., Brickman C. M. and LeWitt P. A. (1995), Transferin and iron in normal, Alzheimer's disease and Parkinson's disease brain region. J. Neurochemistry 65, 710-716.
20. McCord J. M. (1996), Effects of positive iron status at a cellular level. Nutrition Rev. 54, 85-88.
21. Mentlein R., Ludwig R. and Martensen I. (1998), Proteolytic degradation of Alzheimer's disease amyloid β-peptide by a metalloproteinase from microglia cells. J. Neurochem. 70, 721-726.
22. Mills J. and Reiner P. B. (1999), Regulation of Amyloid protein cleavage. J. Neurochemistry 72, 443-460.
23. Montellano P. R. O. (1998), Heme oxygenase mechanism:evidence for an electrophilic, ferric peroxide species. Acc. Chem. Res. 31, 543-549.
24. Nishida Y. and Ito S. (1995a), Structures and reactivity of several iron(III) complexes in the presence of hydrogen peroxide:its relevance to induction of issue damage caused by iron(III) chelates in rats. Polyhedron, 14, 2301-2308.
25. Nishida Y. and Ito S. (1995b), Comparison on reactivity of Fe(III) and Al(III) compounds in the presence of hydrogen peroxide: its relevance to possible origin for central nervous system toxicity by aluminum ion. Z. Naturforsch. 50c, 571-577.
26. Nishida Y., Ito S., Okuno T. and Ohba S. (1997), New insight into reaction of iron(III) -peroxide adduct with alkanes: an alternative model for cytochrome P-450 and methane monooxygenase. Z. Naturforsch. 52c, 615-622.
27. Nishino S., Matsushima H., Tokii T. and Nishida Y. (1999), in press.
28. Okuno T., Ohba S. and Nishida Y. (1997), Oxidation of cyclohexane with hydrogen peroxide catalyzed by copper(II) complexes conatining N,N-bis(2-pyridyl-methyl)-β-alaninamide ligands. Polyhedron 16, 3765-3774.
29. Olanow C. W. (1999), Cell death and neuroprotection in Parkinson's disease. Ann. Neurology 44, Supplement 1.
30. Pazos M., Goto J. J., Rabizadeh S., Gralla E. B., Roe J. A., Lee M. K., Valentine J. S. and Bredesen D. E. (1996), Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271, 515-518.
31. Platis I. E., Ermacora M. R. and Fox R. O. (1993), Oxidative polypeptide cleavage mediated by EDTA-Fe covalently linked to cysteine residues. Biochemistry 32, 12761-12767.
32. Prigge S. T., Kolheker A. S., Eipper B. A., Mains R. E. and Amzel L. M. (1997), Amidation of bioactive peptides:the structure of peptidylglycine α-hydroxylating monooxygenase. Science 278, 1300-1305.
33. Prince R. C. and Gunson D. E. (1998), Prions and copper-binding proteins. Trends Biochem. Sci. 23, 197-198.
34. Prusiner S. B. (1996), Molecular biology and pathogenesis of prion disease. Trends Biochem. Sci. 21, 482-487.
35. Prusiner S. B. (1997), Prion diseases and the BSE crisis. Science 278, 245-251.
36. Prusiner S. B. (1998), Prions, Proc. Natl. Acad. Sci. USA. 95, 13363-13383.
37. Rana T. M. and Meares C. F. (1991), Transfer of oxygen from an artificial protease to peptide carbon during proteolysis. Proc. Natl. Acad. Sci. USA. 88, 10578-10582.
38. Shaw C. E., Enayat Z. E., Chioza B. A., A.-Chalabi A., Radunovic A., Powell J. F. and Leigh P. N. (1998), Mutations in all five exons of SOD-1 may cause ALS. Ann. Neurol. 43, 390-394.
39. Rando T. A., Crowley R. S., Carlson E. J., Epstein C. J. and Mohapatra P. K. (1998), Overexpression of copper/zinc superoxide dismutase: a novel cause of murine muscula dystrophy. Ann. Neurol. 44, 381-386.
40. Simonian N. A. and Coyle J. T. (1996), Oxidative stress in neurodegenerative diseases, Annu. Rev. Pharmacol. Toxicol. 36, 83-106.
41. Smith M. A., Hirai K., Hsiao K., Pappolla M. A., Harris P. L. R., Siedlak S. L., Tabaton M. and Perry G. (1998), Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. J. Neurochemistry 70, 2212-2215.